Suppr超能文献

辉瑞-生物科技公司新冠疫苗接种后贝尔麻痹复发的另一例病例

Another Case of Bell's Palsy Recurrence After Pfizer-BioNTech COVID-19 Vaccination.

作者信息

Zhang Huailin, Sanchez Gomez Diana, Repajic Michael, Liu Antonio K

机构信息

Internal Medicine, Adventist Health White Memorial, Los Angeles, USA.

Family Medicine, Adventist Health White Memorial, Los Angeles, USA.

出版信息

Cureus. 2022 Jul 28;14(7):e27422. doi: 10.7759/cureus.27422. eCollection 2022 Jul.

Abstract

Twenty-seven months into the current pandemic and 18 months after vaccinations were made available, there are still relatively limited data on the incidence of recurrent Bell's Palsy after the administration of mRNA-based vaccines. The authors continue to believe that it is through rigorous reporting that the true incidence can be tabulated eventually.

摘要

在当前疫情爆发27个月以及疫苗可用18个月后,关于接种基于mRNA的疫苗后复发性贝尔麻痹的发病率数据仍然相对有限。作者仍然认为,只有通过严格的报告,最终才能列出真实的发病率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d76/9334026/6d112bde8b85/cureus-0014-00000027422-i01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验